Imprimis Pharma (IMMY) Says it Will Aggressively Defend Itself Against Allergan's (AGN) 'Frivolous Lawsuit' Sep 11, 2017 07:36AM
Imprimis Releases Statement Regarding Allergan Lawsuit Sep 11, 2017 07:30AM
Imprimis Pharma (IMMY) Announces Lower-Cost Option to Valeant's (VRX) Lead Poisoning Treatment Oct 17, 2016 08:34AM
Imprimis Pharmaceuticals Announces Availability of Lower-Cost Option for the Treatment of Lead Poisoning Oct 17, 2016 08:30AM
Imprimis Pharmaceuticals' CEO Mark L. Baum to Debate at the Oxford Union Debating Society Oct 6, 2016 08:30AM


Sep 22, 2016 08:38AM Imprimis Pharma's (IMMY) CEO Publishes Drug Pricing Monograph
Sep 22, 2016 08:30AM Following Congressional Hearing Investigating Mylan and Epi-Pen, Imprimis Pharmaceuticals Founder and CEO Publishes Drug Pricing Monograph
Feb 10, 2016 09:00AM Imprimis Pharmaceuticals to Make a Lower Cost Compounded and Customizable Alternative to Thiola®
Dec 1, 2015 06:24AM Express Scripts (ESRX), Imprimis Pharma (IMMY) to Partner on Low-Cost Alternative to Turing's Daraprim
Dec 1, 2015 12:01AM Express Scripts Champions $1 per Pill Access to an Alternative for Daraprim
Oct 22, 2015 07:35AM Imprimis Pharma (IMMY) Launches Customizable Compounded Formulation of Pyrimethamine + Leucovorin
Oct 22, 2015 07:30AM Imprimis Pharmaceuticals to Make Compounded and Customizable Formulation of Pyrimethamine and Leucovorin Available for Physicians to Prescribe for their Patients as an Alternative to Daraprim®